MedTrace Logo

Perioperative Continuous Glucose Monitoring

NCT05937373 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2025-12-24

Study results available
· View outcomes & findings →

Summary

To evaluate use of continuous glucose monitoring (CGM) technology in the preoperative setting: evaluate feasibility of placement of CGM during preoperative clinic visit with intent to utilize CGM throughout perioperative period.

Conditions

Interventions

DEVICE

Continuous Glucose monitor

Perioperative glucose management beginning preoperative through postoperative monitoring

OTHER

Standard of Care

no study intervention. participant follows current medical providers recommendations for glucose management

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Susan Vishneski, MD · Wake Forest University Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-04
Primary Completion
2024-05-21
Completion
2024-05-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05937373 on ClinicalTrials.gov